Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity

Ziel

The development of anti-drug antibodies is the major complication of treatment with biotherapeutics. This is particularly true
of patients with haemophilia A (HA) who develop neutralizing antibodies to therapeutic factor VIII (FVIII) following
replacement therapy with exogenous pro-coagulant FVIII. The onset of neutralizing antibodies to FVIII, referred to as FVIII
inhibitors, represents a major societal concern owing to the enormous cost associated to the clinical management of
inhibitor-positive patients, that exceeds 200,000€/patient/year. The EDUC8 program is a multidisciplinary training program
with exposure of the enrolled ESRs to a core common educational package and development of individual PhD research
projects dedicated to decreasing the societal burden associated with the development of anti-FVIII antibodies in Europe. The
core educational program includes exposure to basic science in the fields of immunology and hemostasis, to the most
advanced “omic” technologies in order to anticipate tomorrow’s scientific discoveries, and to the importance of ethical
considerations and public awareness in today’s research. A key component of the training program is provided by immersion
of the ESRs in a clinical center for HA, which will provide them with a unique experience and foster the conception of novel
and realistic therapeutic approaches. The ESRs will exploit the accumulated theoretic and practical experience in an
entrepreneurship training on key strategic, technical, financial and human resource issues required for the creation of startups.
In a tribute to the concept of the fully developed mind coined by the French philosopher Michel de Montaigne on
education, our ambition is to form a novel generation of scientists with deep scientific knowledge, multicultural exposure,
imagination, pragmatism and understanding of both the academic and private sectors. This will foster translational research in European on the immunogenicity of therapeutic proteins.

Wissenschaftliches Gebiet (EuroSciVoc)

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

MSCA-ITN - Marie Skłodowska-Curie Innovative Training Networks (ITN)

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) H2020-MSCA-ITN-2019

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Netto-EU-Beitrag
€ 274 802,04
Adresse
RUE DE TOLBIAC 101
75654 Paris
Frankreich
Region
Ile-de-France Ile-de-France Paris
Aktivitätstyp
Research Organisations
Links
Gesamtkosten
€ 274 802,04

Beteiligte (8)